Tune in to our podcast as ValSource experts explore the latest developments and insights within pharmaceutical, advanced therapy medicinal products, biologics and medical device regulated industries.
Continue listening to our podcast series focused on Advanced Therapeutic Medical Products (ATMPs), including cell and gene therapies. Today’s topic is a look-back at the October 2021 ATMP/CGT meeting hosted by the PDA - Parenteral Drug Association – with our panel of experts Darius Pillsbury, Kelly Waldron, PhD, and Virginia Andreotti-Jones.
This is the 5th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that includes cell and gene therapies. Specifically, we'll be discussing ATMP/CGT and Contamination Control strategies.
In the 4th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that includes cell and gene therapies, we'll be discussing ATMP/CGT and working with third parties.
Continue the ATMP discussion with our experts. This episode is focused on working with third parties, what regulations and expectations are out there now, and what might be coming around the corner.
Listen & Learn. ValSource experts explore Phase Appropriate GMPs as they apply to Advanced Therapeutic Medical Products or ATMPs.
Meet the Experts! The first episode in the Advanced Therapeutic Medicinal Products or ATMPs series, including Cell & Gene Therapies.
Our consultants are highly-recognized for their Annex 1 knowledge and expertise. We provide a plan forward through Annex 1 updates, today and into the future.